抗IgE（奥马珠单抗）：慢性鼻-鼻窦炎的一种新治疗方法。 - Suppr

Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.

作者信息

Grundmann Sonja A, Hemfort Pia B, Luger Thomas A, Brehler Randolf

出版信息

J Allergy Clin Immunol. 2008 Jan;121(1):257-8. doi: 10.1016/j.jaci.2007.09.036.

DOI:10.1016/j.jaci.2007.09.036

PMID:18206513

Abstract

摘要

相似文献

Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.

J Allergy Clin Immunol. 2008 Jan;121(1):257-8. doi: 10.1016/j.jaci.2007.09.036.

Recalcitrant nasal polyposis: achievement of total remission following treatment with omalizumab.

J Investig Allergol Clin Immunol. 2009;19(2):158-9.

A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis.

Rhinology. 2010 Sep;48(3):318-24. doi: 10.4193/Rhino09.144.

Anti-IgE monoclonal antibody: a new approach to the treatment of allergic respiratory diseases.

Monaldi Arch Chest Dis. 2003 Jan-Mar;59(1):25-9.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Clin Exp Allergy. 2005 Apr;35(4):408-16. doi: 10.1111/j.1365-2222.2005.02191.x.

Beneficial effects of treatment with anti-IgE antibodies (Omalizumab) in a patient with severe asthma and negative skin-prick test results.

Chest. 2011 Jan;139(1):190-3. doi: 10.1378/chest.10-0128.

What is new in antiimmunoglobulin E asthma therapy.

Allergy Asthma Proc. 2005 Nov-Dec;26(6):428-34.

Omalizumab (Xolair): an anti-IgE antibody for asthma.

Med Lett Drugs Ther. 2003 Aug 18;45(1163):67-8.

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma.

Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93. doi: 10.1164/rccm.200312-1651OC. Epub 2004 Jun 1.

Effects of omalizumab in patients with food allergy.

Allergy Asthma Proc. 2010 Jan-Feb;31(1):76-83. doi: 10.2500/aap.2010.31.3304.

引用本文的文献

Biologic Therapies in Chronic Rhinosinusitis with Nasal Polyposis: Overview of Systematic Reviews and Updated Systematic Review.

Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):650-660. doi: 10.1007/s12070-022-03144-8. Epub 2022 Oct 15.

An Overview of Off-Label Use of Humanized Monoclonal Antibodies in Paediatrics.

Medicina (Kaunas). 2022 Apr 29;58(5):625. doi: 10.3390/medicina58050625.

Biologics for atopic diseases: Indication, side effect management, and new developments.

Allergol Select. 2021 Jan 5;5:1-25. doi: 10.5414/ALX02197E. eCollection 2021.

Clinical Significance of Cytoplasmic IgE-Positive Mast Cells in Eosinophilic Chronic Rhinosinusitis.

Int J Mol Sci. 2020 Mar 7;21(5):1843. doi: 10.3390/ijms21051843.

Successful management of severe asthma in a young boy with eosinophilic chronic rhinosinusitis who received omalizumab: a case report.

Allergy Asthma Clin Immunol. 2019 Sep 5;15:55. doi: 10.1186/s13223-019-0369-7. eCollection 2019.

Novel therapeutic targets for allergic airway disease in children.

Drugs Context. 2019 Jul 9;8:212590. doi: 10.7573/dic.212590. eCollection 2019.

[Immunology of chronic rhinosinusitis with nasal polyps as a basis for treatment with biologicals].

HNO. 2019 Jan;67(1):15-26. doi: 10.1007/s00106-018-0557-7.

Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions.

Am J Rhinol Allergy. 2018 Sep;32(5):412-423. doi: 10.1177/1945892418787132. Epub 2018 Jul 19.

Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis.

Otolaryngol Clin North Am. 2017 Dec;50(6):1135-1151. doi: 10.1016/j.otc.2017.08.009. Epub 2017 Sep 28.

Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments.

Drugs. 2017 Oct;77(16):1713-1721. doi: 10.1007/s40265-017-0803-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anti-IgE (omalizumab): a new therapeutic approach for chronic rhinosinusitis.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献